OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
When Is a Placebo Not a Placebo
Steven E. Nissen
JAMA Cardiology (2022) Vol. 7, Iss. 12, pp. 1183-1183
Closed Access | Times Cited: 6
Steven E. Nissen
JAMA Cardiology (2022) Vol. 7, Iss. 12, pp. 1183-1183
Closed Access | Times Cited: 6
Showing 6 citing articles:
Efferocytosis in atherosclerosis
Shaunak Adkar, Nicholas J. Leeper
Nature Reviews Cardiology (2024) Vol. 21, Iss. 11, pp. 762-779
Closed Access | Times Cited: 34
Shaunak Adkar, Nicholas J. Leeper
Nature Reviews Cardiology (2024) Vol. 21, Iss. 11, pp. 762-779
Closed Access | Times Cited: 34
Association Between Omega‐3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose–Response Meta‐Analysis of Randomized Controlled Trials
Tianjiao Wang, Xin Zhang, Na Zhou, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 11
Open Access | Times Cited: 32
Tianjiao Wang, Xin Zhang, Na Zhou, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 11
Open Access | Times Cited: 32
Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease
Michael Miller
Current Opinion in Cardiology (2024)
Open Access | Times Cited: 3
Michael Miller
Current Opinion in Cardiology (2024)
Open Access | Times Cited: 3
Global eligibility and cost effectiveness of icosapent ethyl in primary and secondary cardiovascular prevention
Peter P. Tóth, Jean Ferrières, M Waters, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Peter P. Tóth, Jean Ferrières, M Waters, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
REDUCE-IT, biomarkers, and confirmation bias: are we missing the forest for the trees?
Samuel Sherratt
European Journal of Preventive Cardiology (2023) Vol. 31, Iss. 15, pp. e113-e114
Open Access | Times Cited: 2
Samuel Sherratt
European Journal of Preventive Cardiology (2023) Vol. 31, Iss. 15, pp. e113-e114
Open Access | Times Cited: 2
The Role of Lipid-Lowering Therapy in Post-Stroke Patients: Update and Recommendations
Eleonora Avenatti, J. A. Carrasco-Avila, Behnam Heidari, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 11, pp. 889-898
Closed Access | Times Cited: 2
Eleonora Avenatti, J. A. Carrasco-Avila, Behnam Heidari, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 11, pp. 889-898
Closed Access | Times Cited: 2
